Concepedia

Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis

Daniel L. Levin, Samira Bell, Reijo Sund, Sirpa Hartikainen, Jaakko Tuomilehto, ­Eero Pukkala, Ilmo Keskimäki, Ellena Badrick, Andrew G. Renehan, Iain Buchan,

Diabetologia · 2014 · 155 citations · 22 references

DOIFull text

Open access

Concepts

References

22

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit et al. · International Journal of Cancer · 2014 · 29K citations · Full text

, , +16

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Jacques Ferlay, Hai‐Rim Shin, Freddie Bray et al. · International Journal of Cancer · 2010 · 21.4K citations

, , +16

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

John Dormandy, B Charbonnel, D.J.A. Eckland et al. · The Lancet · 2005 · 4.1K citations · Full text

, , +15

Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone

James D. Lewis, Assiamira Ferrara, Tiffany Peng et al. · Diabetes Care · 2011 · 621 citations · Full text

, , +13

Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study

Anke Neumann, Alain Weill, P. Ricordeau et al. · Diabetologia · 2012 · 279 citations · Full text

, , +12